Blood cell activation in myeloproliferative neoplasmsCERVANTES, Francisco; ARELLANO-RODRIGO, Eduardo; ALVAREZ-LARRAN, Alberto et al.Haematologica (Roma). 2009, Vol 94, Num 11, pp 1484-1488, issn 0390-6078, 5 p.Article

CryofibrinogenaemiaARELLANO-RODRIGO, Eduardo; PONS, Veronica; NICOLAU, Inmaculada et al.British journal of haematology. 2008, Vol 140, Num 1, pp 2-2, issn 0007-1048, 1 p.Article

Clinical management of thrombosis in inherited factor VII deficiency : A description of two casesARELLANO-RODRIGO, Eduardo; GIRONELLA, Mercedes; NICOLAU, Inmaculada et al.Thrombosis and haemostasis. 2009, Vol 101, Num 2, pp 402-404, issn 0340-6245, 3 p.Article

Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia : long-term results in 30 patientsCERVANTES, Francisco; ALVAREZ- LARRAN, Alberto; DOMINGO, Abel et al.British journal of haematology. 2005, Vol 129, Num 6, pp 771-775, issn 0007-1048, 5 p.Article

Inherited antithrombin deficiency and pregnancy: Maternal and fetal outcomesSABADELL, Jordi; CASELLAS, Manel; ALIJOTAS-REIG, Jaume et al.European journal of obstetrics, gynecology, and reproductive biology. 2010, Vol 149, Num 1, pp 47-51, issn 0301-2115, 5 p.Article

Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia : Relationship with thrombosis occurrence and JAK2 V617F allele burdenARELLANO-RODRIGO, Eduardo; ALVAREZ-LARRAN, Alberto; REVERTER, Juan-Carlos et al.American journal of hematology. 2009, Vol 84, Num 2, pp 102-108, issn 0361-8609, 7 p.Article

Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational statusARELLANO-RODRIGO, Eduardo; ALVAREZ-LARRAN, Alberto; REVERTER, Juan Carlos et al.Haematologica (Roma). 2006, Vol 91, Num 2, pp 169-175, issn 0390-6078, 7 p.Article

Cytoreduction plus low-dose aspirin versus cytoreduction alone as primary prophylaxis of thrombosis in patients with high-risk essential thrombocythaemia: an observational studyALVAREZ-LARRAN, Alberto; PEREIRA, Arturo; ARELLANO-RODRIGO, Eduardo et al.British journal of haematology. 2013, Vol 161, Num 6, pp 865-871, issn 0007-1048, 7 p.Article

Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphomaARELLANO-RODRIGO, Eduardo; LOPEZ-GUILLERMO, Armando; BESSELL, Eric M et al.European journal of haematology. 2003, Vol 70, Num 4, pp 219-224, issn 0902-4441, 6 p.Article

Abdominal computed tomography predicts progression in patients with rai stage 0 chronic lymphocytic leukemiaMUNTANOLA, Ana; BOSCH, Francesc; LOPEZ-GUILLERMO, Armando et al.Journal of clinical oncology. 2007, Vol 25, Num 12, pp 1576-1580, issn 0732-183X, 5 p.Article

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia veraALVAREZ-LARRAN, Alberto; PEREIRA, Arturo; TERUEL, Anabel et al.Blood. 2012, Vol 119, Num 6, pp 1363-1369, issn 0006-4971, 7 p.Article

Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with α-interferonHERNANDEZ-BOLUDA, Juan-Carlos; CARRERAS, Enric; MONTSERRAT, Emili et al.Haematologica (Roma). 2002, Vol 87, Num 1, pp 17-22, issn 0390-6078Article

Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemiaALVAREZ-LARRAN, Alberto; CERVANTES, Francisco; VICENTE, Vicente et al.Blood. 2010, Vol 116, Num 8, pp 1205-1210, issn 0006-4971, 6 p.Article